Innovative strategies also include combining BET inhibitor with the BCG vaccine in melanoma, which reprograms T cells toward an activated state, enhances cytotoxicity, reduces exhaustion, increases intratumoral recruitment, and converts “cold” tumors into “hot” tumors, with efficacy confirmed in humanized PDX models (189). The gene discussed is DNER; the disease is melanoma.